Home > Health & Beauty > Oncology

Oncology

Mesothelioma Cancer Cardio AIDS
Alternative Medicine Biotechnology Clinical Trials
Dental Diabetes FDA
Fitness & Nutrition Genetics Hospitals
Infectious Diseases Medical Devices Medical Supplies
Mental Health Nursing Oncology
Optical Pharmaceutical Radiology
Veterinary
February 10, 2012 20:03
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme today announced its participation in the Leerink Swann 2012 Global Healthcare Conference, the Citi 2012 Global Healthcare Conference, and the Oncology Partnering & Deal Making Conference.
World  World      Oncology  Oncology
February 10, 2012 17:30
SOUTH SAN FRANCISCO, Calif. & BRUSSELS--(BUSINESS WIRE)--Nodality, Inc. and UCB Pharma S.A. (Euronext Brussels: UCB) today announced a strategic collaboration utilizing Nodality’s proprietary Single Cell Network Profiling (SCNP) technology to assist the development of several UCB compounds. The a...
World  World      Oncology  Oncology
February 10, 2012 16:00
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq:EXEL) today announced the pricing of its underwritten public offering of 11,000,000 shares of newly issued common stock at a price to the public of $5.50 per share. Exelixis also granted the underwriters a 30-day option to purch...
World  World      Oncology  Oncology
February 10, 2012 13:05
PORTLAND, Ore.--(BUSINESS WIRE)--Dr. Darm and Aesthetic Medicine are proud to announce that Singer/Songwriter Jared Lee will perform at Charity event to benefit the American Cancer Society Relay for Life Lake Oswego Branch.
World  World      Oncology  Oncology
February 10, 2012 04:02
FORT WASHINGTON, Pa.--(BUSINESS WIRE)--In order to provide people with cancer and their caregivers state-of-the-art treatment information in patient-friendly language, the National Comprehensive Cancer Network® (NCCN®) has developed two new publications: a new release of the NCCN Guidelines for P...
World  World      Oncology  Oncology
February 10, 2012 02:15
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE AMEX: CVM) reports financial results for the fiscal quarter ended December 31, 2011. CEL-SCI reported that net loss available to shareholders for the quarter ended December 31, 2011 was ($4,156,833) versus ($6,250,952) during the same quarte...
World  World      Oncology  Oncology